Phase 1 Study of Ceritinib Combined With Trametinib in Patients With Advanced ALK- or ROS1-Positive NSCLC
| Title: | Phase 1 Study of Ceritinib Combined With Trametinib in Patients With Advanced ALK- or ROS1-Positive NSCLC |
|---|---|
| Authors: | Lara, Matthew S., Gubens, Matthew A., Bacaltos, Bianca, Daran, Lea, Lim, Steffany L., Li, Tianhong, Gandara, David R., Bivona, Trever G., Riess, Jonathan W., Blakely, Collin M. |
| Source: | In JTO Clinical and Research Reports December 2022 3(12) |
| Database: | ScienceDirect |
| ISSN: | 26663643 |
|---|---|
| DOI: | 10.1016/j.jtocrr.2022.100436 |
| Published in: | JTO Clinical and Research Reports |
| Language: | English |